Cepheid
Robert Hofland MSc MBA is a seasoned professional with extensive experience in quality operations and regulatory affairs within the medical technology and life sciences sectors. Currently serving as Vice President of Quality (OUS) at Cepheid since April 2022, Robert oversees strategic direction and compliance across multiple sites. Prior roles include Senior Director of Quality at Advanced Sterilization Products, Director of Quality Operations at BD, and positions at CareFusion, Cardinal Health, Kaz, and Welch Allyn, cumulatively showcasing robust leadership in quality and regulatory compliance. Robert holds two master's degrees, one in Business Administration and Management from the University of Geneva and another in Medical Technology Regulatory Affairs from Cranfield University.
This person is not in the org chart
This person is not in any offices
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.